Cargando…
Development and Characterization of PLGA Nanoparticles Containing 17-DMAG, an Hsp90 Inhibitor
Leishmaniasis is a spectrum of neglected tropical diseases and its cutaneous form (CL) is characterized by papillary or ulcerated skin lesions that negatively impact patients' quality of life. Current CL treatments suffer limitations, such as severe side effects and high cost, making the search...
Autores principales: | Cruz, Kercia P., Patricio, Beatriz F. C., Pires, Vinícius C., Amorim, Marina F., Pinho, Alan G. S. F., Quadros, Helenita C., Dantas, Diana A. S., Chaves, Marcelo H. C., Formiga, Fabio R., Rocha, Helvécio V. A., Veras, Patrícia S. T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161503/ https://www.ncbi.nlm.nih.gov/pubmed/34055735 http://dx.doi.org/10.3389/fchem.2021.644827 |
Ejemplares similares
-
17-DMAG dually inhibits Hsp90 and histone lysine demethylases in alveolar rhabdomyosarcoma
por: Singh, Shivendra, et al.
Publicado: (2020) -
The Hsp90 Inhibitor 17-DMAG Attenuates Hyperglycemia-Enhanced Hemorrhagic Transformation in Experimental Stroke
por: Zhang, Jiaming, et al.
Publicado: (2021) -
The anti-oncogenic effect of 17-DMAG via the inactivation of HSP90 and MET pathway in osteosarcoma cells
por: KAWANO, MASANORI, et al.
Publicado: (2023) -
17-DMAG, an HSP90 Inhibitor, Ameliorates Multiple Organ Dysfunction Syndrome via Induction of HSP70 in Endotoxemic Rats
por: Wang, Yi-Li, et al.
Publicado: (2016) -
Hypoxia attenuates Hsp90 inhibitor 17-DMAG-induced cyclin B1 accumulation in hepatocellular carcinoma cells
por: Zhang, Jianming, et al.
Publicado: (2016)